Colgate-Palmolive Company $CL Shares Acquired by Capitolis Liquid Global Markets LLC

Capitolis Liquid Global Markets LLC increased its holdings in Colgate-Palmolive Company (NYSE:CL) by 24.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 980,627 shares of the company’s stock after buying an additional 191,127 shares during the period. Capitolis Liquid Global Markets LLC’s holdings in Colgate-Palmolive were worth $77,489,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of CL. Norges Bank acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $861,670,000. Northwestern Mutual Wealth Management Co. boosted its position in Colgate-Palmolive by 8,040.1% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,655,987 shares of the company’s stock valued at $380,666,000 after purchasing an additional 4,598,789 shares during the period. Balyasny Asset Management L.P. acquired a new position in Colgate-Palmolive during the 4th quarter valued at approximately $236,682,000. Deutsche Bank AG boosted its position in Colgate-Palmolive by 33.9% during the 4th quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock valued at $857,040,000 after purchasing an additional 2,746,920 shares during the period. Finally, Franklin Resources Inc. boosted its position in Colgate-Palmolive by 47.4% during the 4th quarter. Franklin Resources Inc. now owns 6,044,168 shares of the company’s stock valued at $477,610,000 after purchasing an additional 1,942,946 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 0.3%

Shares of CL stock opened at $90.38 on Thursday. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The stock has a fifty day moving average of $87.18 and a two-hundred day moving average of $86.52. The firm has a market capitalization of $72.32 billion, a PE ratio of 35.17, a price-to-earnings-growth ratio of 4.78 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.22 billion. During the same quarter in the previous year, the firm posted $0.91 EPS. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. As a group, research analysts expect that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s payout ratio is 82.49%.

Analyst Ratings Changes

CL has been the subject of a number of analyst reports. Wall Street Zen lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. Sanford C. Bernstein initiated coverage on Colgate-Palmolive in a research report on Thursday, June 11th. They set a “market perform” rating and a $96.00 price objective for the company. Rothschild & Co Redburn set a $100.00 price objective on Colgate-Palmolive and gave the company a “buy” rating in a research report on Tuesday, April 21st. UBS Group boosted their price objective on Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $99.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. Twelve investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.